Abalos Therapeutics Appoints Thomas Bogenrieder as Chief Medical Officer
Abalos Therapeutics announced today the appointment of Thomas Bogenrieder, MD, PhD, as Chief Medical Officer. Dr. Bogenrieder will contribute more than 17 years of international clinical development
New York United States Memorial Sloan Kettering Cancer Center Kostenloser Wertpapierhandel Thomas Bogenrieder Marie Theresa Weickert
Source: finanznachrichten.de